Pharmacist-led Medication Therapy Management to improve anticoagulant safety after colorectal cancer surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program integrates multifaceted pharmacist interventions at admission, during hospitalization, and after discharge to manage anticoagulant therapy in postoperative colorectal cancer patients with venous thromboembolism. The MTM model includes medication reconciliation, monitoring, individualized dosing and follow-up counseling to reduce inappropriate prescribing, premature treatment discontinuation, and adverse events. Participants are patients with histologically confirmed colorectal cancer who developed symptomatic or incidental VTE and are on active anticoagulant therapy for at least three months. The study compares outcomes of MTM-managed care against usual care to measure recurrent VTE, bleeding events, and overall medication appropriateness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients with histologically confirmed CRC and symptomatic or incidental VTE who received anticoagulant treatment.
2. CRC patients with VTE treated with an anticoagulant for at least 3 moths.

Exclusion Criteria:

1.Participation in this study required active anticoagulant treatment. Apart from this, there were no specific exclusion criteria.

Where it's running

• Sixth Affiliated Hospital, Sun Yat-sen University
  Guangzhou, Guangdong, China Recruiting

Study contacts

• Principal investigator: xiaoyan li — Sixth Affiliated Hospital, Sun Yat-sen University
• Study coordinator: xiaoyan li
• Email: lixyan5@mail.sysu.edu.cn
• Phone: 13609066172

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating mechanical thrombectomy for deep vein thrombosis

  This study is testing if a procedure called mechanical thrombectomy can safely help people with serious blood clots in their legs feel better.

  Recruiting IRCCS San Raffaele · Milan, Italy · NCT06288906

• Bioimpedance and light-based monitoring during abdominal flap weaning in breast reconstruction

  This study tests a portable bioimpedance device alongside light and temperature measurements to monitor a breast reconstruction flap during arterial and venous weaning in adult women.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT05710705

• Danang Cerebral Venous Thrombosis Registry

  This registry collects information on adults with cerebral venous thrombosis admitted to Danang Hospital to see how the condition presents, what imaging shows, risk factors, and how patients recover.

  Recruiting Da Nang Hospital · Da Nang, Da Nang · NCT07890675

• Anticoagulation Plus Tocilizumab for Acute Cerebral Venous Thrombosis

  This study tests whether adding a single dose of tocilizumab to standard blood thinners helps people with acute cerebral venous thrombosis.

  Recruiting Capital Medical University · Beijing, Beijing Municipality · NCT07801638

• Anticoagulation plus batroxobin for acute cerebral venous thrombosis

  This trial tests whether adding batroxobin to standard anticoagulation helps adults with acute cerebral venous thrombosis.

  Recruiting Phase 4 Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT07352358

• DOAC treatment outcomes for cerebral venous thrombosis in Vietnam

  This project will try direct oral anticoagulants (dabigatran or rivaroxaban) in adults with cerebral venous thrombosis to see if they are safe and effective in routine care.

  Recruiting Bach Mai Hospital · Hanoi, Hanoi · NCT07083609

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.